Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K H Rahn

Showing results (11-20 of 217) with videos related to

Pageof 22
Sort By:
Cardiology|January 1, 1978
[Properties of various beta receptor blockaders. Which are relevant?]K H Rahn
Hippokrates|March 1, 1972
[Therapy of essential hypertension]K H Rahn
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1971
[Influence of guanethidine (ismelin) on the urinary excretion of noradrenaline in hypertensive patients]K H Rahn
The American Journal of Cardiology|April 3, 1990
Principles of antihypertensive drug treatmentK H Rahn
Der Internist|March 1, 1974
[Differential therapeutic principles in the drug therapy of high blood pressure]K H Rahn
European Heart Journal|July 1, 1983
Haemodynamic effects of the optical isomers of beta-receptor blocking agentsK H Rahn
Medizinische Klinik (Munich, Germany : 1983)|June 13, 2000
[German Society for Internal Medicine at the turn of the millenium: review and perspectives]K H Rahn
Journal of Cardiovascular Pharmacology|January 1, 1987
Antihypertensive compounds with combined actionsK H Rahn
Archives Internationales De Pharmacodynamie Et De Therapie|January 1, 1980
The influence of beta receptor blocking drugs on plasma catecholamine levels in patients with essential hypertensionK H Rahn
MMW Fortschritte Der Medizin|December 12, 2007
[Are beta blockers no longer the medicines of choice for the treatment of hypertension?]K H Rahn
Pageof 22

Showing results (11-20 of 217) with videos related to

Sort By:
Pageof 22
Cardiology|January 1, 1978
[Properties of various beta receptor blockaders. Which are relevant?]K H Rahn
Hippokrates|March 1, 1972
[Therapy of essential hypertension]K H Rahn
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1971
[Influence of guanethidine (ismelin) on the urinary excretion of noradrenaline in hypertensive patients]K H Rahn
The American Journal of Cardiology|April 3, 1990
Principles of antihypertensive drug treatmentK H Rahn
Der Internist|March 1, 1974
[Differential therapeutic principles in the drug therapy of high blood pressure]K H Rahn
European Heart Journal|July 1, 1983
Haemodynamic effects of the optical isomers of beta-receptor blocking agentsK H Rahn
Medizinische Klinik (Munich, Germany : 1983)|June 13, 2000
[German Society for Internal Medicine at the turn of the millenium: review and perspectives]K H Rahn
Journal of Cardiovascular Pharmacology|January 1, 1987
Antihypertensive compounds with combined actionsK H Rahn
Archives Internationales De Pharmacodynamie Et De Therapie|January 1, 1980
The influence of beta receptor blocking drugs on plasma catecholamine levels in patients with essential hypertensionK H Rahn
MMW Fortschritte Der Medizin|December 12, 2007
[Are beta blockers no longer the medicines of choice for the treatment of hypertension?]K H Rahn
Pageof 22